2018 (4th) International Symposium on Next-Generation CAR & TCR-T Cells
In-Person Event
Nov 23 - 24, 2018
Shanghai, Shanghai, CN
OVERVIEW
2018 (4th) International Symposium on Next-Generation CAR & TCR-T Cells is organized by Bioon and will be held from Nov 23 - 24, 2018 at Hope Hotel Shanghai, Shanghai, China.
Course Description:
Chimeric antigen receptors (CARs) are engineered receptors that combine a new specificity with an immune cell to target cancer cells. Typically, these receptors graft the specificity of a monoclonal antibody onto a T cell. The receptors are called chimeric because they are fused of parts from different sources. CAR-T cells are a new type of treatment that uses living cells that have been transformed.
These T-cells are genetically engineered to express an artificial T cell receptor, through which they are targeted to disease-related antigens. This process is MHC independent and thus the targeting efficiency is greatly increased. Progress need to be made in treatment of solid tumors. Besides, CAR-T cells are developed to be specific to an antigen expressed on a tumor that is not expressed on healthy cells. Apart from these, novel cellular immunotherapies like TCR-T and CAR-NK are under development.
Additional details will be posted as soon as they are available.
Course Description:
Chimeric antigen receptors (CARs) are engineered receptors that combine a new specificity with an immune cell to target cancer cells. Typically, these receptors graft the specificity of a monoclonal antibody onto a T cell. The receptors are called chimeric because they are fused of parts from different sources. CAR-T cells are a new type of treatment that uses living cells that have been transformed.
These T-cells are genetically engineered to express an artificial T cell receptor, through which they are targeted to disease-related antigens. This process is MHC independent and thus the targeting efficiency is greatly increased. Progress need to be made in treatment of solid tumors. Besides, CAR-T cells are developed to be specific to an antigen expressed on a tumor that is not expressed on healthy cells. Apart from these, novel cellular immunotherapies like TCR-T and CAR-NK are under development.
Additional details will be posted as soon as they are available.
KEY DATES
23 Nov, 2018
Event Start Date
24 Nov, 2018
Event End Date
SPECIALITIES
ImmunotherapiesImmunology and MicrobiologySUGGESTED HOTELS
CONFERENCE VENUE
Hope Hotel Shanghai
Quick Links